首页> 外国专利> NEW TRIAZINE SUBSTANCE FOR USE IN THE TREATMENT OF CANCER, SPECIFICALLY IN THE TREATMENT OF NON-SMALL CELL CANCER, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID SUBSTANCE

NEW TRIAZINE SUBSTANCE FOR USE IN THE TREATMENT OF CANCER, SPECIFICALLY IN THE TREATMENT OF NON-SMALL CELL CANCER, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID SUBSTANCE

机译:新的三嗪类物质,用于治疗癌症,特别是用于治疗非小细胞癌以及包含所述物质的药物成分

摘要

Substance of formula (I) for use as a medicamentwherein A is a [-(CH2)n-] spacer, n being an integer comprised between 1 and 3, preferably between 1 and 2 ; Xm are m substituents, m being an integer comprised between 1 and 3, wherein X is chosen among Cl, Br, OCH3 or SCH3; and R1, R2, R3 and R4 are chosen among hydrogen atoms or C1-C3 alkyl groups. This substance has an anti-proliferative action on tumor cells and may advantageously be for use in the treatment of non-small cell cancer, preferably for use in the treatment of non-small cell squamous carcinoma, and more preferably for use in the treatment of non-small cell lung cancer.
机译:用作药物的式(I)物质 <图像文件=“ IMGA0001.GIF” he =“ 78” id =“ ia01” imgContent =“ chem” imgFormat =“ GIF” wi =“ 117” /> 其中A为[-(CH 2 )n-]间隔基,n为1至3,优选1至2的整数; X m 为m个取代基,m为1至3的整数,其中X选自Cl,Br,OCH 3 或SCH 3 ;和R 1 ,R 2 ,R 3 和R 4 选自氢原子或C 1 -C 3 烷基。该物质对肿瘤细胞具有抗增殖作用,可有利地用于治疗非小细胞癌,优选用于治疗非小细胞鳞癌,更优选用于治疗非小细胞鳞癌。非小细胞肺癌。

著录项

  • 公开/公告号EP3381909A1

    专利类型

  • 公开/公告日2018-10-03

    原文格式PDF

  • 申请/专利权人 UNIVERSITE DE NANTES;

    申请/专利号EP20170305361

  • 发明设计人 ROUSSAKIS CHRISTOS;ROBERT JEAN-MICHEL;

    申请日2017-03-29

  • 分类号C07D251/18;A61K31/53;A61P35;

  • 国家 EP

  • 入库时间 2022-08-21 13:16:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号